OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Checkpoint inhibitor responses can be regulated by the gut microbiota – A systematic review
M. Zeriouh, Hans Raskov, Lasse Kvich, et al.
Neoplasia (2023) Vol. 43, pp. 100923-100923
Open Access | Times Cited: 13
M. Zeriouh, Hans Raskov, Lasse Kvich, et al.
Neoplasia (2023) Vol. 43, pp. 100923-100923
Open Access | Times Cited: 13
Showing 13 citing articles:
Benefits of a diverse gut microbiome in systemic anti-cancer therapy patients
Beth Pantlin
British Journal of Nursing (2025) Vol. 34, Iss. 1, pp. 8-12
Closed Access
Beth Pantlin
British Journal of Nursing (2025) Vol. 34, Iss. 1, pp. 8-12
Closed Access
Interplay between gut microbial communities and metabolites modulates pan-cancer immunotherapy responses
Xiaoqiang Zhu, Muni Hu, Xiaowen Huang, et al.
Cell Metabolism (2025)
Closed Access
Xiaoqiang Zhu, Muni Hu, Xiaowen Huang, et al.
Cell Metabolism (2025)
Closed Access
Gut microbial predictors of first-line immunotherapy efficacy in advanced NSCLC patients
Anna Grenda, Ewelina Iwan, Barbara Kuźnar-Kamińska, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Anna Grenda, Ewelina Iwan, Barbara Kuźnar-Kamińska, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Prioritizing gut microbial SNPs linked to immunotherapy outcomes in NSCLC patients by integrative bioinformatics analysis
Muhammad Faheem Raziq, N. A. Khan, Haseeb Manzoor, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Muhammad Faheem Raziq, N. A. Khan, Haseeb Manzoor, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Immune cells mediate the causal relationship between the gut microbiota and different types of endometrial cancer: A bidirectional two-sample, two-step Mendelian randomization study
Shu-yang Yu, Wan Shu, Jiarui Zhang, et al.
Research Square (Research Square) (2025)
Closed Access
Shu-yang Yu, Wan Shu, Jiarui Zhang, et al.
Research Square (Research Square) (2025)
Closed Access
Recent developments on checkpoint inhibitors, CAR T cells, and beyond for T cell-based immunotherapeutic strategies against cancer
Shaukat Ali, Mahnoor Arshad, Muhammad Summer, et al.
Journal of Oncology Pharmacy Practice (2025)
Closed Access
Shaukat Ali, Mahnoor Arshad, Muhammad Summer, et al.
Journal of Oncology Pharmacy Practice (2025)
Closed Access
Proton pump inhibitors reduce nivolumab efficacy in unresectable advanced or recurrent gastric cancer
Masahito Shibano, Masaya Takahashi, Hitomi Nakatsukasa, et al.
Immunotherapy (2025), pp. 1-8
Closed Access
Masahito Shibano, Masaya Takahashi, Hitomi Nakatsukasa, et al.
Immunotherapy (2025), pp. 1-8
Closed Access
Exploring Gut Microbiota Alterations with Trimethoprim-Sulfamethoxazole and Dexamethasone in a Humanized Microbiome Mouse Model
George B. H. Green, Alexis N. Cox-Holmes, Olivia Backan, et al.
Microorganisms (2024) Vol. 12, Iss. 5, pp. 1015-1015
Open Access | Times Cited: 2
George B. H. Green, Alexis N. Cox-Holmes, Olivia Backan, et al.
Microorganisms (2024) Vol. 12, Iss. 5, pp. 1015-1015
Open Access | Times Cited: 2
Hepatocellular Carcinoma: The Evolving Role of Systemic Therapies as a Bridging Treatment to Liver Transplantation
Yacob Saleh, Taher Abu Hejleh, Maen Abdelrahim, et al.
Cancers (2024) Vol. 16, Iss. 11, pp. 2081-2081
Open Access | Times Cited: 2
Yacob Saleh, Taher Abu Hejleh, Maen Abdelrahim, et al.
Cancers (2024) Vol. 16, Iss. 11, pp. 2081-2081
Open Access | Times Cited: 2
Narrative Review: Advancing Dysbiosis Treatment in Onco-Hematology with Microbiome-Based Therapeutic Approach
Salomé Biennier, Mathieu Fontaine, Aurore Duquenoy, et al.
Microorganisms (2024) Vol. 12, Iss. 11, pp. 2256-2256
Open Access | Times Cited: 2
Salomé Biennier, Mathieu Fontaine, Aurore Duquenoy, et al.
Microorganisms (2024) Vol. 12, Iss. 11, pp. 2256-2256
Open Access | Times Cited: 2
Charting cancer’s course: revealing the role of diet, exercise, and the microbiome in cancer evolution and immunotherapy response
Ana Isabel Martín-Quesada, Maeve Hennessy, Ana Cardeña Gutiérrez
Clinical & Translational Oncology (2024)
Open Access | Times Cited: 1
Ana Isabel Martín-Quesada, Maeve Hennessy, Ana Cardeña Gutiérrez
Clinical & Translational Oncology (2024)
Open Access | Times Cited: 1
Low abundant intestinal commensals modulate immune control of chronic myeloid leukemia stem cells
Magdalena Hinterbrandner, Francesca Ronchi, Viviana Rubino, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Magdalena Hinterbrandner, Francesca Ronchi, Viviana Rubino, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Associations of the gut microbiome with outcomes in cervical and endometrial cancer patients treated with pembrolizumab: Insights from the phase II PRIMMO trial
Emiel A. De Jaeghere, Hannelore Hamerlinck, Sandra Tuyaerts, et al.
Gynecologic Oncology (2024) Vol. 191, pp. 275-286
Closed Access
Emiel A. De Jaeghere, Hannelore Hamerlinck, Sandra Tuyaerts, et al.
Gynecologic Oncology (2024) Vol. 191, pp. 275-286
Closed Access
